Access comprehensive financial analyses and make smarter investments - get the Manual of Investments on Amazon!

OLN

Olin Corporation appoints retired U.S. Army General to Board

Olin Corporation (NYSE: OLN) has appointed retired U.S. Army General Edward M. Daly to its board of directors, effective March 5, 2025. General Daly brings extensive expertise in defense procurement and logistics, having served in the U.S. Army for over 36 years. He previously led the U.S. Army Materiel Command, overseeing logistics and materiel readiness with an annual budget exceeding $50 billion.

Since his retirement, General Daly has been involved in various ventures, including founding Virtus 9, an innovative startup focused on enhancing U.S. national security, and serving as president of Daly Consulting & Logistics. He also holds positions on the boards of and serves as an advisor to several companies, including SkyWater Technology and ZenSights LLC.

General Daly's appointment to Olin's board of directors is expected to bring a fresh perspective, given his extensive military background and understanding of global trade and security. Olin's President & CEO, Ken Lane, expressed enthusiasm about General Daly joining the board, citing his leadership and insight as valuable assets that will help guide the company's growth across all its businesses.

Olin Corporation is a leading vertically integrated global manufacturer and distributor of chemical products, as well as a prominent U.S. manufacturer of ammunition. The company's chemical products include chlorine, caustic soda, vinyls, epoxies, chlorinated organics, bleach, hydrogen, and hydrochloric acid. Additionally, its Winchester division produces and distributes a range of ammunition, including sporting ammunition, law enforcement ammunition, and small caliber military ammunition, among others. Today the company's shares have moved -1.6% to a price of $24.58. For more information, read the company's full 8-K submission here.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.

IN FOCUS